A novel viewpoint of an imidazole derivative ionic liquid as an additive for cobalt and nickel electrodeposition.

Thin films of Co and Ni electroplated onto a copper electrode from acidic sulfate and Watts baths, respectively, were investigated. The use of an ionic liquid additive in the electrolyte is widespread for producing thin films by electrodeposition. In the present work, the influence of a new ionic liquid, namely, 1-methyl-3-((2-oxo-2-(2,4,5-trifluorophenyl)amino)ethyl)-1H-imidazol-3-ium iodide (Im-IL), in the electrodeposition of two metals was investigated using cathodic polarization (CP), cyclic voltammetry (CV), and anodic linear stripping voltammetry (ALSV) measurements and cathodic current efficiency (CCE%). The surface morphology of the Co- and Ni-coated samples was examined using Scanning electron microscopy (SEM), energy dispersive X-ray spectroscopy (EDX), X-ray diffraction (XRD) and atomic force microscopy (AFM). The corrosion protection of the Co and Ni samples in a marine environment (3.5% NaCl solution) was studied by the potentiodynamic polarization and electrochemical impedance spectroscopy (EIS) techniques. The results show that the addition of Im-IL inhibits Co2+ and Ni2+ deposition, which leads to more fine-grained deposits, especially at low Im-IL concentrations. The inhibition of Co2+ and Ni2+ reduction in the presence of Im-IL ions occurs via adsorption, which obeys the Langmuir adsorption isotherm. The CCE% is higher in the presence of Im-IL. SEM images show smoother deposits of Co and Ni in 1 × 10-5 M and 1 × 10-4 M Im-IL solution respectively. The results prove that Im-IL acts as an efficient additive for electroplating soft Co and Ni films.

Biocompatibility and bioactivity of hardystonite-based nanocomposite scaffold for tissue engineering applications.

Bone injury, especially bone damages due to the removal of bone tumors, is one of the most important issues in the field of therapeutic research in tissue engineering applications. In this context, ceramic-based composites have attracted widespread attention since they have mechanical properties close to the natural bone, hence providing similar conditions for the extracellular matrix (ECM). Thus, in this study, hardystonite and diopside (HT-Di) scaffolds containing various diopside amounts from 5 to 25 wt% were prepared by the space holder method. The results revealed that the fabricated scaffolds contain 70%-75% porosity with a pore size of 300-500 µm and a compressive strength of about 0.54 to 1.71 MPa which is perfectly in the range of the compressive strength of the sponge bone. Noticeably, great apatite formation ability was observed in the scaffold with diopside, although the scaffold without diopside showed poor bioactivity. The MTT assay depicted that the inclusion of diopside into hardystonite scaffold resulted in dramatic enhancement in the MG-63 cell viability. Moreover, the scaffold with diopside offered greater cell attachment and spreading than the scaffold without diopside. Therefore, the synergistic effects of the scaffold with 12.5 wt% of diopside, including great mechanical characteristic, excellent bioactivity, and appealing biocompatibility enable it to be an appealing choice for bone tissue engineering applications.

Adsorption and in vitro release study of curcumin form polyethyleneglycol functionalized multi walled carbon nanotube: kinetic and isotherm study.

Polyethylene glycol functionalized with oxygenated multi-walled carbon nanotubes (O-PEG-MWCNTs) as an efficient nanomaterial for the in vitro adsorption/release of curcumin (CUR) anticancer agent. The synthesized material was morphologically characterized using scanning electron microscopy, Fourier transform infrared spectroscopy and transmission electron microscopy. In addition, the CUR adsorption process was assessed with kinetic and isotherm models fitting well with pseudo-second order and Langmuir isotherms. The results showed that the proposed O-PEG-MWCNTs has a high adsorption capacity for CUR (2.0 × 103 mg/g) based on the Langmuir model. The in vitro release of CUR from O-PEG-MWCNTs was studied in simulating human body fluids with different pHs (ABS pH 5, intestinal fluid pH 6.6 and body fluid pH 7.4). Lastly, to confirm the success compliance of the O-PEG-MWCNT nanocomposite as a drug delivery system, the parameters affecting the CUR release such as temperature and PEG content were investigated. As a result, the proposed nanocomposite could be used as an efficient carrier for CUR delivery with an enhanced prolonged release property. Graphical Abstract ᅟ.